Vanguard Group Inc Iovance Biotherapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 27,313,967 shares of IOVA stock, worth $205 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,313,967

Previous 25,950,644 5.25%

Holding current value

$205 Million

Previous $208 Million 23.23%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.28 - $11.9 $9.92 Million - $16.2 Million	1,363,323 Added 5.25%	27,313,967 $256 Million
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $8.05 Million - $14.7 Million	1,035,344 Added 4.16%	25,950,644 $208 Million
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $16 Million - $36.7 Million	2,102,480 Added 9.22%	24,915,300 $369 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $2.21 Million - $5.95 Million	669,350 Added 3.02%	22,812,820 $185 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $7.76 Million - $15.4 Million	1,748,082 Added 8.57%	22,143,470 $101 Million
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $36.7 Million - $62.1 Million	6,855,259 Added 50.63%	20,395,388 $144 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $5.1 Million - $7.59 Million	-922,953 Reduced 6.38%	13,540,129 $82.7 Million
Q4 2022 Feb 10, 2023	BUY	$5.62 - $10.0 $1.18 Million - $2.09 Million	209,328 Added 1.47%	14,463,082 $92.4 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $8.49 Million - $11.7 Million	890,727 Added 6.67%	14,253,754 $137 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $6.52 Million - $18.7 Million	1,021,374 Added 8.28%	13,363,027 $148 Million
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $1.78 Million - $2.75 Million	143,866 Added 1.18%	12,341,653 $205 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $4.45 Million - $7.43 Million	268,798 Added 2.25%	12,197,787 $233 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $6.26 Million - $8.19 Million	-307,422 Reduced 2.51%	11,928,989 $294 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $200 Million - $405 Million	12,236,411 New	12,236,411 $318 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Iovance Biotherapeutics, Inc. Transaction History